These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31969034)

  • 21. Local Side Effects of Sublingual and Oral Immunotherapy.
    Passalacqua G; Nowak-Węgrzyn A; Canonica GW
    J Allergy Clin Immunol Pract; 2017; 5(1):13-21. PubMed ID: 27527548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines.
    Manzano AI; Javier Cañada F; Cases B; Sirvent S; Soria I; Palomares O; Fernández-Caldas E; Casanovas M; Jiménez-Barbero J; Subiza JL
    Glycoconj J; 2016 Feb; 33(1):93-101. PubMed ID: 26603537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral effector memory regulatory T cells are incremented and functionally enhanced in successful mite monomeric allergoid sublingual immunotherapy.
    Petrarca C; Lanuti P; Petrosino MI; Di Pillo S; Mistrello G; Compalati E; Otzuki T; Marchisio M; Pierdomenico L; Paganelli R; Di Gioacchino M
    Allergy; 2021 Jul; 76(7):2208-2211. PubMed ID: 33284458
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
    Gotoh M; Okubo K; Yuta A; Ogawa Y; Nagakura H; Ueyama S; Ueyama T; Kawashima K; Yamamoto M; Fujieda S; Sakashita M; Sakamoto H; Iwasaki N; Mori E; Endo T; Ohta N; Kitazawa H; Okano M; Asako M; Takada M; Terada T; Inaka Y; Yonekura S; Matsuoka T; Kaneko S; Hata H; Hijikata N; Tanaka H; Masuyama K; Okamoto Y
    Allergol Int; 2020 Jan; 69(1):104-110. PubMed ID: 31421989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis.
    Sayed KM; Kamel AG; Ali AH
    Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1989-1996. PubMed ID: 31209565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.
    Lund K; Kito H; Skydtsgaard MB; Nakazawa H; Ohashi-Doi K; Lawton S
    Clin Ther; 2019 Apr; 41(4):742-753. PubMed ID: 30885398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
    Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
    Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ranking in importance of allergen extract characteristics for sublingual immunotherapy by Italian specialists.
    Canonica GW; Passalacqua G; Incorvaia C; Cadario G; Fiocchi A; Senna G; Rossi O; Romano A; Scala E; Romano C; Ingrassia A; Zambito M; Dell'Albani I; Frati F
    Allergy Asthma Proc; 2014; 35(1):43-6. PubMed ID: 24433596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study.
    Lombardi C; Gargioni S; Melchiorre A; Tiri A; Falagiani P; Canonica GW; Passalacqua G
    Allergy; 2001 Oct; 56(10):989-92. PubMed ID: 11576079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-Life Effectiveness of Subcutaneous Immune Therapy with Carbamylated Monomeric Allergoids on Mite, Grass, and Pellitory Respiratory Allergy: A Retrospective Study.
    Di Gioacchino M; Della Valle L; Mangifesta R; Lumaca A; Cipollone F; Frati F; Compalati E; Lekli E; Loloci EQ; Santilli F
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fast up-dosing with a birch allergoid is safe and well tolerated in allergic rhinitis patients with or without asthma.
    Zielen S; Plückhahn K; Akboga Y; Rieker-Schwienbacher J; Thieme U; Rosewich M
    Immunotherapy; 2019 Feb; 11(3):177-187. PubMed ID: 30730274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study.
    Reiber R; Keller M; Keller W; Wolf H; Schnitker J; Wüstenberg E
    Clin Transl Allergy; 2015; 6():9. PubMed ID: 26958338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early cytokine modulation after the rapid induction phase of sublingual immunotherapy with mite monomeric allergoids.
    Di Gioacchino M; Perrone A; Petrarca C; Di Claudio F; Mistrello G; Falagiani P; Dadorante V; Verna N; Braga M; Ballone E; Cavallucci E
    Int J Immunopathol Pharmacol; 2008; 21(4):969-76. PubMed ID: 19144282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patients.
    Masuyama K; Goto M; Takeno S; Ohta N; Okano M; Kamijo A; Suzuki M; Terada T; Sakurai D; Horiguchi S; Honda K; Matsune S; Yamada T; Sakashita M; Yuta A; Fuchiwaki T; Miyanohara I; Nakayama T; Okamoto Y; Fujieda S
    Auris Nasus Larynx; 2016 Feb; 43(1):1-9. PubMed ID: 26615715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML; Bruno ME; Falagiani P; Riva G
    Allergol Immunopathol (Madr); 2006; 34(5):194-8. PubMed ID: 17064648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allergoids for Allergy Treatment.
    Carnes J; Gallego MT; Moya R; Iraola V
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):110-119. PubMed ID: 29473530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical aspects of sublingual immunotherapy tablets and drops.
    Tankersley M; Han JK; Nolte H
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):573-582. PubMed ID: 31923544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of sublingual immunotherapy in the treatment of asthma: An updated systematic review.
    Lin SY; Azar A; Suarez-Cuervo C; Diette GB; Brigham E; Rice J; Ramanathan M; Robinson KA
    Int Forum Allergy Rhinol; 2018 Sep; 8(9):982-992. PubMed ID: 29885036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.